Saturna Capital CORP Has $68.03 Million Position in Agilent Technologies Inc (NYSE:A)

Saturna Capital CORP grew its position in Agilent Technologies Inc (NYSE:A) by 0.0% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 911,103 shares of the medical research company’s stock after buying an additional 269 shares during the quarter. Agilent Technologies accounts for about 2.0% of Saturna Capital CORP’s portfolio, making the stock its 15th largest holding. Saturna Capital CORP owned about 0.29% of Agilent Technologies worth $68,032,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the company. Stratos Wealth Partners LTD. increased its position in Agilent Technologies by 2.7% during the 1st quarter. Stratos Wealth Partners LTD. now owns 31,792 shares of the medical research company’s stock worth $2,555,000 after purchasing an additional 850 shares in the last quarter. Prentiss Smith & Co. Inc. increased its position in Agilent Technologies by 484.9% during the 2nd quarter. Prentiss Smith & Co. Inc. now owns 58,428 shares of the medical research company’s stock worth $4,363,000 after purchasing an additional 48,438 shares in the last quarter. TimesSquare Capital Management LLC increased its position in Agilent Technologies by 0.7% during the 1st quarter. TimesSquare Capital Management LLC now owns 1,007,700 shares of the medical research company’s stock worth $80,999,000 after purchasing an additional 7,200 shares in the last quarter. Nordea Investment Management AB increased its position in Agilent Technologies by 510.5% during the 1st quarter. Nordea Investment Management AB now owns 112,292 shares of the medical research company’s stock worth $9,028,000 after purchasing an additional 93,898 shares in the last quarter. Finally, Mason Street Advisors LLC increased its position in Agilent Technologies by 0.8% during the 1st quarter. Mason Street Advisors LLC now owns 45,312 shares of the medical research company’s stock worth $3,642,000 after purchasing an additional 370 shares in the last quarter.

A has been the subject of a number of research analyst reports. Deutsche Bank lowered their price objective on shares of Agilent Technologies from $90.00 to $85.00 and set a “buy” rating for the company in a research report on Wednesday, May 15th. Zacks Investment Research lowered shares of Agilent Technologies from a “hold” rating to a “sell” rating and set a $71.00 target price on the stock. in a report on Tuesday, July 16th. Piper Jaffray Companies assumed coverage on shares of Agilent Technologies in a report on Tuesday, June 11th. They set an “overweight” rating and a $83.00 target price on the stock. Bank of America lowered shares of Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 target price on the stock. in a report on Tuesday, July 16th. Finally, Wolfe Research began coverage on shares of Agilent Technologies in a report on Thursday, May 30th. They set a “peer perform” rating on the stock. One analyst has rated the stock with a sell rating, five have given a hold rating and ten have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $83.92.

A traded up $1.28 during trading on Tuesday, hitting $67.91. 130,513 shares of the company’s stock were exchanged, compared to its average volume of 2,762,785. The company has a current ratio of 3.41, a quick ratio of 2.82 and a debt-to-equity ratio of 0.35. The firm’s 50 day moving average price is $71.09. Agilent Technologies Inc has a fifty-two week low of $61.01 and a fifty-two week high of $82.27. The company has a market cap of $21.69 billion, a PE ratio of 24.33, a P/E/G ratio of 1.91 and a beta of 1.41.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Tuesday, May 14th. The medical research company reported $0.71 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.72 by ($0.01). Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. The business had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the previous year, the company posted $0.65 EPS. The business’s quarterly revenue was up 2.7% on a year-over-year basis. As a group, research analysts expect that Agilent Technologies Inc will post 3.05 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd were issued a $0.164 dividend. The ex-dividend date was Monday, July 1st. This represents a $0.66 annualized dividend and a dividend yield of 0.97%. Agilent Technologies’s dividend payout ratio is currently 23.66%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: How Do You Calculate Return on Equity (ROE)?

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.